Zobrazeno 1 - 3
of 3
pro vyhledávání: '"María E. Sanhueza"'
Autor:
María E. Sanhueza, Pamela San Martín, Loreto Brantes, Sylvia Caro, Guillermo Carrasco, Eduardo Machuca
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
SARS-CoV-2 has had a great impact on world health, patients on hemodialysis have a higher rate of infection and death due to COVID-19. Vaccination is important to control infection and improve the prognosis of infected patients. To describe the effic
Externí odkaz:
https://doaj.org/article/861f082ffa0d4005a946ca523d7bab13
Autor:
Ana M Ortiz, Rodrigo A Sepúlveda, Rubén Torres, René Clavero, Luis Toro, Miguel Albornoz, Tatiana Aldunate, Ingrid Arce, Juan Arévalo, Andrés Arriagada, Julieta Becker, Sonia C González, Waldo Bernales, Eduardo Briones, Álvaro Castillo, Agustín Fuentes, Esteban Gómez, Hernán Jaramillo, Mario Lillo, Eduardo Lorca, Eduardo Machuca, Rodrigo Mansilla, Serwin Menéndez, Carlos Moya, Carolina Muñoz, William Neilson, Rodrigo Orozco, María Padrino, Edgard Pais, Gonzalo Ramírez, María E Sanhueza, Herman Schneider, Ruth Solís, Jaime Troncoso, Marcela Ursu, Marcela Valenzuela
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 42(5)
The Covid-19 pandemic has been responsible for millions of deaths worldwide. Patients with comorbidities– such as those on peritoneal dialysis (PD)– present higher morbidity and mortality than the general population. We prospectively evaluated al
Autor:
Felipe Simon, Pablo Tapia, Ricardo Armisen, Cesar Echeverria, Sebastian Gatica, Alejandro Vallejos, Alejandro Pacheco, Maria E. Sanhueza, Miriam Alvo, Erico Segovia, Rubén Torres
Publikováno v:
Frontiers in Physiology, Vol 8 (2017)
Chronic peritoneal dialysis (PD) therapy is equally efficient as hemodialysis while providing greater patient comfort and mobility. Therefore, PD is the treatment of choice for several types of renal patients. During PD, a high-glucose hyperosmotic (
Externí odkaz:
https://doaj.org/article/12ce798315f1485d8fa9b6cc7e2bdf9a